0HKE.L
Axon Enterprise, Inc. [0HKE.L] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
0HKE.L Stock Summary
Top 0HKE.L Correlated Resources
0HKE.L
Top 10 Correlated ETFs
0HKE.L
Top 10 Correlated Stocks
0HKE.L
In the News
0HKE.L Financial details
0HKE.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 7.19 | 6.02 | 11.85 | 13.09 | 16.42 | |
| Net income per share | 0.5 | 0.01 | -0.03 | -0.91 | 2.03 | |
| Operating cash flow per share | 1.09 | 0.74 | 0.67 | 1.89 | 3.25 | |
| Free cash flow per share | 0.9 | 0.56 | -0.59 | 1.13 | 2.48 | |
| Cash per share | 5.98 | 3.98 | 9.78 | 6.72 | 13.45 | |
| Book value per share | 8 | 6.16 | 16.99 | 15.89 | 17.5 | |
| Tangible book value per share | 8.78 | 5.73 | 16.39 | 14.99 | 16.71 | |
| Share holders equity per share | 8 | 6.16 | 16.99 | 15.89 | 17.5 | |
| Interest debt per share | 0 | 0 | 0 | 0 | 9.3 | |
| Market cap | 11.52B | 17.39B | 11.33B | 10.42B | 11.95B | |
| Enterprise value | 11.17B | 17.22B | 11.17B | 10.07B | 11.59B | |
| P/E ratio | 394.32 | 19.72K | -6.57K | -173.64 | 81.19 | |
| Price to sales ratio | 27.41 | 32.76 | 16.64 | 12.07 | 10.04 | |
| POCF ratio | 180.29 | 264.79 | 294.43 | 83.71 | 50.76 | |
| PFCF ratio | 218.37 | 349.65 | -331.79 | 139.68 | 66.53 | |
| P/B Ratio | 24.64 | 32 | 11.61 | 9.95 | 9.42 | |
| PTB ratio | 24.64 | 32 | 11.61 | 9.95 | 9.42 | |
| EV to sales | 26.58 | 32.43 | 16.41 | 11.66 | 9.74 | |
| Enterprise value over EBITDA | 298.13 | 2.47K | -23.53K | -67.36 | 94.3 | |
| EV to operating cash flow | 174.82 | 262.17 | 290.39 | 80.85 | 49.26 | |
| EV to free cash flow | 211.75 | 346.19 | -327.24 | 134.91 | 64.56 | |
| Earnings yield | 0 | 0 | 0 | -0.01 | 0.01 | |
| Free cash flow yield | 0 | 0 | 0 | 0.01 | 0.02 | |
| Debt to equity | 0 | 0 | 0 | 0 | 0.53 | |
| Debt to assets | 0 | 0 | 0 | 0 | 0.24 | |
| Net debt to EBITDA | -9.33 | -24.72 | 327.24 | 2.38 | -2.88 | |
| Current ratio | 3.36 | 3.12 | 3.83 | 2.65 | 3 | |
| Interest coverage | 0 | 0 | 0 | 0 | 0 | |
| Income quality | 2.19 | 74.46 | -22.32 | -2.07 | 1.6 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.37 | 0.4 | 0.45 | 0.6 | 0.34 | |
| Research and developement to revenue | 0.18 | 0.19 | 0.18 | 0.22 | 0.2 | |
| Intangibles to total assets | 0.06 | 0.04 | 0.03 | 0.03 | 0.02 | |
| Capex to operating cash flow | -0.17 | -0.24 | -1.89 | -0.4 | -0.24 | |
| Capex to revenue | -0.03 | -0.03 | -0.11 | -0.06 | -0.05 | |
| Capex to depreciation | -1.05 | -1.4 | -5.82 | -2.67 | -2.29 | |
| Stock based compensation to revenue | 0.05 | 0.15 | 0.2 | 0.35 | 0.09 | |
| Graham number | 9.49 | 1.18 | 3.39 | 18.04 | 28.27 | |
| ROIC | 0.06 | 0 | -0.02 | -0.25 | 0.04 | |
| Return on tangible assets | 0.04 | 0 | 0 | -0.04 | 0.05 | |
| Graham Net | 5.29 | 2.34 | 7.34 | 3.53 | -1.26 | |
| Working capital | 392.14M | 413.91M | 725.62M | 690.97M | 1.2B | |
| Tangible asset value | 512.61M | 505.71M | 941.6M | 988.79M | 1.21B | |
| Net current asset value | 392.14M | 307.33M | 577.18M | 469.13M | 221.88M | |
| Invested capital | 0 | 0 | 0 | 0 | 0.53 | |
| Average receivables | 100.3M | 164.76M | 239.06M | 397.19M | 528.17M | |
| Average payables | 11.88M | 20.52M | 25.01M | 28.18M | 46.07M | |
| Average inventory | 39.61M | 36.3M | 64.4M | 99.32M | 155.58M | |
| Days sales outstanding | 125.59 | 127.19 | 157.12 | 211.9 | 170.27 | |
| Days payables outstanding | 34.27 | 42.24 | 33.29 | 36.47 | 47.41 | |
| Days of inventory on hand | 76.31 | 63.42 | 124.06 | 123.02 | 160.2 | |
| Receivables turnover | 2.91 | 2.87 | 2.32 | 1.72 | 2.14 | |
| Payables turnover | 10.65 | 8.64 | 10.96 | 10.01 | 7.7 | |
| Inventory turnover | 4.78 | 5.76 | 2.94 | 2.97 | 2.28 | |
| ROE | 0.06 | 0 | 0 | -0.06 | 0.12 | |
| Capex per share | -0.19 | -0.18 | -1.26 | -0.76 | -0.77 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 4.37 | 4.62 | 4.64 | 4.83 | 5.43 | |
| Net income per share | 0.17 | 0.4 | 0.61 | 0.16 | 0.78 | |
| Operating cash flow per share | 0.57 | 1.8 | -0.76 | 0.55 | 0.83 | |
| Free cash flow per share | 0.37 | 1.64 | -0.88 | 0.38 | 0.64 | |
| Cash per share | 5.29 | 13.39 | 14.78 | 14.61 | 15.63 | |
| Book value per share | 17.26 | 17.43 | 18.96 | 18.62 | 19.98 | |
| Tangible book value per share | 16.44 | 16.64 | 18.2 | 17.59 | 18.96 | |
| Share holders equity per share | 17.26 | 17.43 | 18.96 | 18.62 | 19.98 | |
| Interest debt per share | 0 | 9.26 | 9.12 | 8.7 | 8.88 | |
| Market cap | 8.4B | 12B | 16.83B | 15.24B | 15.26B | |
| Enterprise value | 8.25B | 11.64B | 16.57B | 14.76B | 14.85B | |
| P/E ratio | 173.05 | 102.79 | 93.22 | 306.7 | 64.21 | |
| Price to sales ratio | 26.94 | 35.68 | 49.07 | 40.67 | 36.88 | |
| POCF ratio | 205.3 | 91.48 | -298.84 | 357.21 | 242.56 | |
| PFCF ratio | 316.52 | 100.35 | -259.6 | 516.18 | 311.85 | |
| P/B Ratio | 6.82 | 9.46 | 12 | 10.54 | 10.03 | |
| PTB ratio | 6.82 | 9.46 | 12 | 10.54 | 10.03 | |
| EV to sales | 26.46 | 34.63 | 48.3 | 39.41 | 35.9 | |
| Enterprise value over EBITDA | 219.84 | 341.88 | 711.18 | 309.24 | 243.76 | |
| EV to operating cash flow | 201.69 | 88.78 | -294.16 | 346.09 | 236.1 | |
| EV to free cash flow | 310.95 | 97.39 | -255.54 | 500.11 | 303.55 | |
| Earnings yield | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow yield | 0 | 0.01 | 0 | 0 | 0 | |
| Debt to equity | 0 | 0.53 | 0.48 | 0.47 | 0.44 | |
| Debt to assets | 0 | 0.24 | 0.22 | 0.22 | 0.21 | |
| Net debt to EBITDA | -3.94 | -10.39 | -11.31 | -9.93 | -6.67 | |
| Current ratio | 2.79 | 3 | 3.33 | 3.38 | 3.15 | |
| Interest coverage | 0 | 0 | 0 | 0 | 0 | |
| Income quality | 3.37 | 4.49 | -1.25 | 3.43 | 1.06 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0.34 | 0 | 0 | 0 | |
| Research and developement to revenue | 0.19 | 0.2 | 0.21 | 0.19 | 0.19 | |
| Intangibles to total assets | 0.03 | 0.02 | 0.02 | 0.03 | 0.02 | |
| Capex to operating cash flow | -0.35 | -0.09 | 0.15 | -0.31 | -0.22 | |
| Capex to revenue | -0.05 | -0.03 | -0.02 | -0.04 | -0.03 | |
| Capex to depreciation | -2.32 | -1.87 | -1.27 | -1.76 | -1.66 | |
| Stock based compensation to revenue | 0.09 | 0.09 | 0.1 | 0.09 | 0.07 | |
| Graham number | 8.12 | 12.54 | 16.13 | 8.19 | 18.72 | |
| ROIC | 0.01 | 0.01 | 0.01 | 0.06 | 0.02 | |
| Return on tangible assets | 0.01 | 0.01 | 0.02 | 0 | 0.02 | |
| Graham Net | 1.76 | -1.25 | 0.62 | 1.25 | 1.51 | |
| Working capital | 774.18M | 1.2B | 1.44B | 1.49B | 1.54B | |
| Tangible asset value | 1.17B | 1.21B | 1.35B | 1.37B | 1.44B | |
| Net current asset value | 426.58M | 221.88M | 447.74M | 480.24M | 524.78M | |
| Invested capital | 0 | 0.53 | 0.48 | 0.47 | 0.44 | |
| Average receivables | 581.7M | 571.04M | 575.92M | 612.06M | 665.36M | |
| Average payables | 55.44M | 55.06M | 62.95M | 69.49M | 81.51M | |
| Average inventory | 163.67M | 187.76M | 211.37M | 235.02M | 254.94M | |
| Days sales outstanding | 169.46 | 148.62 | 156.56 | 150.73 | 153.05 | |
| Days payables outstanding | 38.12 | 41.33 | 42.74 | 46.1 | 51.18 | |
| Days of inventory on hand | 131.43 | 139.67 | 142.68 | 157.77 | 147.86 | |
| Receivables turnover | 0.53 | 0.61 | 0.57 | 0.6 | 0.59 | |
| Payables turnover | 2.36 | 2.18 | 2.11 | 1.95 | 1.76 | |
| Inventory turnover | 0.68 | 0.64 | 0.63 | 0.57 | 0.61 | |
| ROE | 0.01 | 0.02 | 0.03 | 0.01 | 0.04 | |
| Capex per share | -0.2 | -0.16 | -0.12 | -0.17 | -0.18 |
0HKE.L Frequently Asked Questions
What is Axon Enterprise, Inc. stock symbol ?
Axon Enterprise, Inc. is a US stock , located in Scottsdale of Az and trading under the symbol 0HKE.L
What is Axon Enterprise, Inc. stock quote today ?
Axon Enterprise, Inc. stock price is $235.77 today.
Is Axon Enterprise, Inc. stock public?
Yes, Axon Enterprise, Inc. is a publicly traded company.
Company Profile
- Volume Average 1.05K
- Market Capitalization 17.74B
- Employee 2.82K
- CEO Mr. Patrick W. Smith
- Headquarters Scottsdale,AZ,US
- IPO Date 2018-01-29
-
Website
https://www.axon.com 
Axon Enterprise, Inc. develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, TASER, and Software and Sensors. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence. Its products include TASER 7, TASER X26P, TASER X2, TASER Consumer devices, and related cartridges; on-officer body cameras, Axon Fleet in-car systems, and other devices; Axon Evidence digital evidence management software; Axon Signal enabled devices, as well as hardware extended warranties; and Axon docks, cartridges, and batteries. It sells its products through its direct sales force, distribution partners, online store, and third-party resellers. Axon Enterprise, Inc. has a strategic partnership with Fusus, Inc. to expand the capabilities of Axon Respond and the Fusus Real Time Crime Center in the Cloud solution to provide agencies real-time operations situational awareness, including streamlined investigative workflows. The company was formerly known as TASER International, Inc. and changed its name to Axon Enterprise, Inc. in April 2017. Axon Enterprise, Inc. was incorporated in 1993 and is headquartered in Scottsdale, Arizona.
